Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 1/20 | 0.72 |
| ▸ | TUBB | P07437 | 1/20 | 0.72 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.72 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.72 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.72 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.72 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.72 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.72 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.72 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.72 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.72 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.72 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.72 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.72 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099801 | 1.00 | TUBB4A (0.72) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1043764 | 1.00 | TUBB4A (0.72) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1043766 | 1.00 | TUBB4A (0.72) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1045232 | 0.91 | TUBB4A (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1045233 | 0.91 | TUBB4A (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL20691419 | 0.90 | TUBB4A (0.70) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1307051 | 0.88 | TUBB4A (0.77) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1308260 | 0.88 | TUBB4A (0.77) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1041943 | 0.87 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1041944 | 0.87 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515443-B1 | COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A BENZOPHENONE THIAZOLE DERIVATIVE AS A VDA AND A TOPOISOMERASE INHIBITOR | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2022-06-22 | — | — | EP | claimed |
| US-20210236468-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING A VASCULAR DISRUPTING AGENT AND TAXANE COMPOUND | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2021-08-05 | — | — | US | claimed |
| US-11045452-B2 | Composition for preventing or treating cancer comprising a vascular disrupting agent and immune checkpoint inhibitor | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2021-06-29 | — | — | US | claimed |
| EP-3793555-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING A VASCULAR DISRUPTING AGENT AND TAXANE COMPOUND | Chong Kun Dang Pharmaceutical Corp. (KR) | 2021-03-24 | — | — | EP | claimed |
| CN-112040946-A | Composition for preventing or treating cancer comprising a vascular blocking agent and a taxane compound | 株式会社钟根堂 | 2020-12-04 | — | — | CN | claimed |
| EP-3658143-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A VASCULAR DISRUPTING AGENT AND IMMUNE CHECKPOINT INHIBITOR | Chong Kun Dang Pharmaceutical Corp. (KR) | 2020-06-03 | — | — | EP | claimed |
| US-20200163942-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A VASCULAR DISRUPTING AGENT AND IMMUNE CHECKPOINT INHIBITOR | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2020-05-28 | — | — | US | claimed |
| CN-110913856-A | Composition for preventing or treating cancer comprising a vascular disrupting agent and an immune checkpoint inhibitor | 株式会社钟根堂 | 2020-03-24 | — | — | CN | claimed |
| WO-2019022501-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A VASCULAR DISRUPTING AGENT AND IMMUNE CHECKPOINT INHIBITOR | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2019-01-31 | — | — | WO | claimed |
| US-9980953-B2 | Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitor | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2018-05-29 | — | — | US | claimed |
| WO-2018021827-A1 | COMPOSITIONS FOR TREATING LIVER CANCER COMPRISING A VASCULAR DISRUPTING AGENT | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2018-02-01 | — | — | WO | claimed |
| EP-2272845-B1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | CHONG KUN DANG PHARM CORP (KR) | 2015-03-04 | — | — | EP | claimed |
| US-8362267-B2 | Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2013-01-29 | — | — | US | claimed |
| US-20110021582-A1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2011-01-27 | — | — | US | claimed |
| EP-2272845-A2 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2011-01-12 | — | — | EP | claimed |
| EP-3515443-B1 | COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A BENZOPHENONE THIAZOLE DERIVATIVE AS A VDA AND A TOPOISOMERASE INHIBITOR | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2022-06-22 | — | — | EP | disclosed |
| CN-109789136-B | Pharmaceutical combination composition for preventing or treating colorectal cancer | 株式会社钟根堂 | 2021-12-21 | — | — | CN | disclosed |
| US-20110021582-A1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2011-01-27 | — | — | US | disclosed |
| US-20110021582-A1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2011-01-27 | — | — | US | disclosed |
| US-20110021582-A1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021582-A1 | BENZOPHENONE THIAZOLE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE AND METHOD FOR PRODUCING THE SAME | TUBB1, TUBA1C, MAP2 | TUBB4A 11/4885TUBB 5/4885TUBA3C 23/4885 |
| US-20200163942-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A VASCULAR DISRUPTING AGENT AND IMMUNE CHECKPOINT INHIBITOR | CD274, PDCD1, CD47 | TUBB4A 3170/4885TUBB 3376/4885TUBA3C 3625/4885 |
| US-20210236468-A1 | COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING A VASCULAR DISRUPTING AGENT AND TAXANE COMPOUND | TEK, TIE1, FLT4 | TUBB4A 61/4885TUBB 63/4885TUBA3C 82/4885 |
| US-11045452-B2 | Composition for preventing or treating cancer comprising a vascular disrupting agent and immune checkpoint inhibitor | CD274, PDCD1, CD47 | TUBB4A 3170/4885TUBB 3376/4885TUBA3C 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.